for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

CHF Solutions Inc

CHFS.OQ

Latest Trade

0.79USD

Change

0.05(+6.67%)

Volume

39,237

Today's Range

0.73

 - 

0.82

52 Week Range

0.60

 - 

13.90

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
0.74
Open
0.73
Volume
39,237
3M AVG Volume
16.63
Today's High
0.82
Today's Low
0.73
52 Week High
13.90
52 Week Low
0.60
Shares Out (MIL)
4.22
Market Cap (MIL)
3.11
Forward P/E
-0.11
Dividend (Yield %)
--

Latest Developments

More

CHF Solutions Announces Launch Of Ultrafiltration Therapy Using Aquadex Flexflow System

CHF Solutions, Inc. Announces Third Quarter Financial Results And Provides Company Update

Bigger Capital Fund LP Reports A Passive Stake Of 8.3% In CHF Solutions Inc

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About CHF Solutions Inc

CHF Solutions, Inc., formerly Sunshine Heart, Inc., is a medical device company. The Company is focused on commercializing the Aquadex FlexFlow System. The Aquadex FlexFlow System (Aquadex) is indicated for temporary (up to eight hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy. Aquadex is also indicated for extended (longer than 8 hours) ultrafiltration treatment of patients with fluid overloads who have failed diuretic therapy and require hospitalization.

Industry

Medical Equipment & Supplies

Contact Info

12988 Valley View Rd

+1.952.3454200

https://www.chf-solutions.com/

Executive Leadership

John L. Erb

Chairman of the Board, President, Chief Executive Officer

Claudia Drayton

Chief Financial Officer, Secretary

Vitaliy Epshteyn

Vice President of Operations and Engineering

Gordon Weber

Vice President, General Counsel

Carrie Powers

Vice President - Marketing

Key Stats

1.00 mean rating - 1 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2017

0.0K

2018

0.0K

2019(E)

0.0K
EPS (USD)

2017

-2.258

2018

-42.140

2019(E)

-6.450
Price To Earnings (TTM)
--
Price To Sales (TTM)
0.55
Price To Book (MRQ)
0.49
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
0.00
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
-248.47
Return on Equity (TTM)
-185.00

Latest News

Latest News

BRIEF-CHF Solutions Says Qtrly Basic, Diluted Loss Per Share $1.08

* CHF SOLUTIONS, INC. ANNOUNCES 25 PERCENT INCREASE IN REVENUES FOR FIRST QUARTER 2018 OVER PREVIOUS QUARTER AND PROVIDES COMPANY UPDATE

BRIEF-CHF Solutions Expands European Distribution With New Agreement In Italy

* CHF SOLUTIONS INC EXPANDS EUROPEAN DISTRIBUTION WITH NEW AGREEMENT IN ITALY

BRIEF-CHF Solutions Expands Operations into Hong Kong

* CHF SOLUTIONS, INC. EXPANDS OPERATIONS INTO HONG KONG; RECEIVES FIRST COMMERCIAL ORDERS FOR BOTH HONG KONG AND SINGAPORE

BRIEF-CHF Solutions Initiates Distribution Agreement In Spain

* CHF SOLUTIONS, INC. INITIATES DISTRIBUTION AGREEMENT IN SPAIN

BRIEF-CHF Solutions Q4 Revenue Rose 11.4 Percent

* CHF SOLUTIONS, INC. ANNOUNCES 11.4 PERCENT REVENUE GROWTH FOR ITS FOURTH QUARTER AND PROVIDES COMPANY UPDATE

BRIEF-CHF Solutions Enters Into International Distribution Agreement With Transmedic Pte Ltd

* CHF SOLUTIONS - ENTERS INTERNATIONAL DISTRIBUTION AGREEMENT WITH TRANSMEDIC PTE LTD TO MARKET & SUPPORT CO'S AQUADEX FLEXFLOW SYSTEM IN SINGAPORE-REGION Source text for Eikon: Further company coverage:

BRIEF-Chiang Li Family Reports A 13.1 Percent Passive Stake In CHF Solutions

* CHIANG LI FAMILY REPORTS A 13.1 PERCENT PASSIVE STAKE IN CHF SOLUTIONS INC AS ON NOV 22 - SEC FILING Source: (http://bit.ly/2AFJcq6) Further company coverage:

BRIEF-CHF SOLUTIONS REPORTS QTRLY LOSS PER SHARE ‍$4.55

* CHF SOLUTIONS, INC. ANNOUNCES 21% REVENUE GROWTH FOR ITS THIRD QUARTER, 2017 AND PROVIDES COMPANY UPDATE

BRIEF-CHF Solutions files for offering of up to $8.0 mln of common stock

* CHF Solutions Inc files for offering of up to $8.0 million of common stock - SEC filing Source text : (http://bit.ly/2zyK7aG) Further company coverage:

BRIEF-Trend Discovery reports 5.05 pct passive stake in CHF Solutions

* Trend Discovery LP reports 5.05 percent passive stake in CHF Solutions as of Oct 12 - SEC filing Source text: (http://bit.ly/2gfbEt9) Further company coverage:

BRIEF-CHF SOLUTIONS ANNOUNCES 1 FOR 20 REVERSE SPLIT RATIO

* ANNOUNCED A 1-FOR-20 REVERSE SPLIT OF ITS COMMON STOCK, EFFECTIVE OCT 12 Source text for Eikon: Further company coverage:

BRIEF-CHF Solutions Q2 loss per share $0.47

* CHF Solutions, Inc. announces 18 pct revenue growth for its second quarter and provides company update

BRIEF-CHF Solutions commences manufacturing transition of aquadex flexflow system to its minnesota facility

* has begun process of transitioning manufacturing of aquadex flexflow system from unit of Baxter International to co's facility in minnesota Source text for Eikon: Further company coverage:

BRIEF-CHF's Aquadex Flexflow aquapheresis system receives FDA IDE approval for clinical study for pediatric use

* CHF Solutions’ aquadex flexflow® aquapheresis system receives FDA IDE approval for clinical study for pediatric use Source text for Eikon: Further company coverage:

BRIEF-Richard Abbe reports 5.8 pct passive stake in CHF Solutions

* Richard Abbe reports 5.8 percent passive stake in CHF Solutions Inc as of june 6 - sec filing Source text - http://bit.ly/2sbOs0d Further company coverage:

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up